8th German Pharm-Tox Summit

The single nucleotide polymorphism rs7121 in the gene <em>GNAS</em> as a biomarker for tumor progression and poor survival in intrahepatic cholangiocellular carcinoma patients

G-protein coupled receptors

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Session 1

Poster

Cancer pharmacology	

Individuals with weaker humoral response after second booster vaccination are prone to SARS-CoV-2 Omicron BA.5 infections

Immunopharmacology / inflammation / anti-infectives	

Immunopharmacology and inflammation 

Oral presentation

Disease models, drug development

Prof.

Winfried Siffert

Weitere Beteiligungen